Home  /  Resource Library  /  Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimization

Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimization

Real world study of CAR-T tisagenlecleucel for treatment of relapsed DLBCL in Australia.